IFN-γ is also shown to reduce the progression to chronic myocarditis and DCM via increasing the CD4+CD25+T regulatory population and reducing fibrosis and pericarditis [60, 61]. The gene discussed is IFNG; the disease is familial dilated cardiomyopathy.